Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.80% | -99.80% | -99.97% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Financials (USD)
Sales 2021 | 17.5M | Sales 2022 | 49.72M | Capitalization | 111M |
---|---|---|---|---|---|
Net income 2021 | -64M | Net income 2022 | -51M | EV / Sales 2021 | 5.55 x |
Net Debt 2021 | 7.2M | Net Debt 2022 | 12.95M | EV / Sales 2022 | 2.49 x |
P/E ratio 2021 |
-1.12
x | P/E ratio 2022 |
-1.95
x | Employees | 125 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.32% |
Latest transcript on RVL Pharmaceuticals plc
1 day | -99.80% |
Managers | Title | Age | Since |
---|---|---|---|
Sergio Alegre
CMP | Compliance Officer | - | 16-07-31 |
James Schaub
COO | Chief Operating Officer | 42 | 15-12-31 |
Michael Depetris
AUD | Comptroller/Controller/Auditor | - | 22-04-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Cowan
BRD | Director/Board Member | 70 | 18-12-31 |
Alisa Lask
BRD | Director/Board Member | 53 | 22-08-09 |
Michael DeBiasi
BRD | Director/Board Member | 48 | 19-09-30 |
1st Jan change | Capi. | |
---|---|---|
-99.97% | 111 | |
+0.10% | 91.42B | |
+3.16% | 41.08B | |
-11.10% | 34.26B | |
+53.99% | 25.27B | |
-9.41% | 12.81B | |
-12.25% | 11.6B | |
-44.00% | 11.42B | |
+5.77% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- RVLPQ Stock